SANGAMO THERAPEUTICS, INC. Payments for Restructuring
SANGAMO THERAPEUTICS, INC. (SGMOQ) reported Payments for Restructuring of $344.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2026-03-30
- SANGAMO THERAPEUTICS, INC. payments for restructuring for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- SANGAMO THERAPEUTICS, INC. payments for restructuring for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- SANGAMO THERAPEUTICS, INC. payments for restructuring for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- SANGAMO THERAPEUTICS, INC. payments for restructuring for the quarter ending 2025-03-31 was $344.00K, a 93.35% decline year-over-year.
- SANGAMO THERAPEUTICS, INC. payments for restructuring for fiscal 2025 was $344.00K, a 96.92% decline from fiscal 2024.
- SANGAMO THERAPEUTICS, INC. payments for restructuring for fiscal 2024 was $11.18M, a 161.07% increase from fiscal 2023.
- SANGAMO THERAPEUTICS, INC. payments for restructuring for fiscal 2023 was $4.28M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 derived: sum of 3 quarters · filed 2026-03-30 | $344.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $344.00K 10-Q · filed 2025-11-06 | $840.00K derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $344.00K 10-Q · filed 2025-08-07 | $840.00K derived: sum of 3 quarters · filed 2026-03-30 | $2.05M derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-03-31 | $344.00K 10-Q · filed 2025-05-12 | $840.00K derived: sum of 2 quarters · filed 2026-03-30 | $2.05M derived: sum of 3 quarters · filed 2026-03-30 | $6.35M derived: sum of 4 quarters · filed 2026-03-30 |
| 2024-12-31 | $496.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.71M derived: sum of 2 quarters · filed 2026-03-30 | $6.01M derived: sum of 3 quarters · filed 2026-03-30 | $11.18M 10-K · filed 2026-03-30 |
| 2024-09-30 | $1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $5.51M derived: sum of 2 quarters · filed 2024-11-12 | $10.68M 10-Q · filed 2024-11-12 | $11.93M derived: sum of 4 quarters · filed 2025-03-17 |
| 2024-06-30 | $4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $9.47M 10-Q · filed 2024-08-06 | $10.72M derived: sum of 3 quarters · filed 2025-03-17 | $12.57M derived: sum of 4 quarters · filed 2025-03-17 |
| 2024-03-31 | $5.17M 10-Q · filed 2024-05-09 | $6.42M derived: sum of 2 quarters · filed 2025-03-17 | $8.27M derived: sum of 3 quarters · filed 2025-03-17 | |
| 2023-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $3.10M derived: sum of 2 quarters · filed 2025-03-17 | $4.28M 10-K · filed 2025-03-17 | |
| 2023-09-30 | $1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $3.03M 10-Q · filed 2023-11-01 | ||
| 2023-06-30 | $1.18M 10-Q · filed 2023-08-08 |